A T cell redirection platform for co-targeting dual antigens on solid tumors-Reference-Cited by-同舟云学术

A T cell redirection platform for co-targeting dual antigens on solid tumors

Published:2021-01-01 Issue:1 Volume:13 Page:
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Enderle Leonie¹²,Shalaby Karim H.¹²,Gorelik Maryna¹²,Weiss Alexander¹²,Blazer Levi L.¹²^ORCID,Paduch Marcin³,Cardarelli Lia¹²,Kossiakoff Anthony³⁴,Adams Jarrett J.¹²,Sidhu Sachdev S.¹²

Affiliation:

1. Donnelly Centre, University of Toronto, Toronto, Canada

2. Department of Molecular Genetics, University of Toronto, Toronto, Canada

3. Institute for Biophysical Dynamics, Gordon Center for Integrative Science, Chicago, USA

4. Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, USA

Funder

Genome Canada

Terry Fox Research Institute

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/19420862.2021.1933690

Reference70 articles.

1. Novel immunotherapies for hematologic malignancies

2. Antibody-Based Immunotherapy of Cancer

3. CARs versus BiTEs: A Comparison between T Cell–Redirection Strategies for Cancer Treatment

Monoclonal antibody therapy of solid tumors: clinical limitations and novel strategies to enhance treatment efficacy

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A nanobody-guided multifunctional T cell engager promotes strong anti-tumor responses via synergistic immuno-photothermal effects;Journal of Nanobiotechnology;2024-09-14

2. Engineered antigen‐binding fragments for enhanced crystallization of antibody:antigen complexes;Protein Science;2023-12-20

3. Nanobody-based trispecific T cell engager (Nb-TriTE) enhances therapeutic efficacy by overcoming tumor-mediated immunosuppression;Journal of Hematology & Oncology;2023-11-29

4. Engineered Antigen-Binding Fragments for Enhanced Crystallisation of Antibody:Antigen Complexes;2023-07-06